Research in immune evasion is rapidly evolving. Scientists are exploring new ways to identify and target the mechanisms cancer cells use to evade the immune system. Advances in genomics and proteomics are helping to uncover novel targets for therapy. Additionally, personalized medicine approaches are being developed to tailor immunotherapies to individual patients based on the specific characteristics of their tumors.
